Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Pima subjects homozygous for the Trp64Arg beta 3-adrenergic-receptor mutation have an earlier onset of NIDDM and tend to have a lower resting metabolic rate. 7609750

1995

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg allele of the beta 3-adrenergic receptor is associated with abdominal obesity and resistance to insulin and may contribute to the early onset of NIDDM: 7609751

1995

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Recently, a missense mutation replacing tryptophan with arginine at codon 64 of the beta 3-adrenergic receptor gene was shown to be associated with insulin resistance in nondiabetic subjects and to an earlier onset of NIDDM in Pima Indians. 8690160

1996

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE These data suggest that the Trp64Arg mutation not only contributes to weight gain and age-at-onset of NIDDM but is also associated with susceptibility to NIDDM. 8721782

1996

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE In conclusion, the TRP64ARG beta 3AR mutation or any other mutation in the beta 3AR gene is not a major contributor to genetic susceptibility to NIDDM and obesity likely in Nauruans. 8923875

1996

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is unlikely to be a major genetic predisposer to NIDDM or insulin resistance syndrome in subjects from eastern Finland. 9250462

1997

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg allele of the beta 3-AR gene was significantly more frequent in the NIDDM patients with PDR (P = 0.002), but not in those with non-PDR (P = 0.151), than in NIDDM patients without diabetic retinopathy. 9313761

1997

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Non-diabetic subjects heterozygous for the mutation were more obese and Trp/Arg diabetics had a slightly younger age of onset of NIDDM (47 vs 51 years, respectively), but there were no significant differences in mutation frequency between the two groups.Metabolic parameters (e.g. fasting lipids and glycaemic control) were similar among diabetic subjects with and without the Trp64Arg mutation.3. 9315379

1997

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. 9709965

1998

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Heterozygosity for the Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not accompanied by obesity, impaired glucose tolerance and type 2 diabetes mellitus in the general elderly Dutch population, and is also not associated with changes in circulating leptin levels. 9828912

1998

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg mutation is not a major determinant of Type 2 diabetes and its microangiopathic complications. 10197086

1998

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg beta3AR variant is associated in some, but not all, studies with an earlier onset of Type 2 diabetes mellitus and features of the insulin resistance syndrome. 10441039

1999

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus. 10981554

2000

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Our results suggest that the Trp64Arg mutation is not a major determinant of metabolic disorders (type 2 diabetes, obesity) and chronic complications of type 2 diabetes in a Dutch population. 11213599

2001

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg)--adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes. 11380082

2001

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. 11522702

2001

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE In conclusion, no major difference was associated with the beta3AR Trp64Arg or FABP2 Ala54Thr polymorphism in terms of type 2 diabetes or hyperlipidemia in young to older Japanese men. 11699048

2001

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The beta(3)-adrenergic receptor gene (BAR-3) allelic variant (Trp64Arg and Arg64Arg) is correlated with obesity or non-insulin-dependent diabetes mellitus. 12943691

2003

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE To determine whether this SNP affects insulin resistance syndrome associated with type 2 diabetes, we examined its effects on susceptibility to obesity, hyperlipidemia and hypertension in type 2 diabetic subjects and on susceptibility to type 2 diabetes by interaction with other frequent genes involved in lipid metabolism, namely, beta3-adrenergic receptor (b3AR) Trp64Arg, phosphodiesterase 3B (PDE3B) c.1389G>A or lysosomal acid lipase (LAL) Thr-6Pro. 12965109

2003

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE The Trp64Arg polymorphism in the beta3AR gene has been reported to be associated with insulin resistance, obesity and type 2 diabetes; little is known about its possible association with cancer. 15743038

2004

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Thus, heterozygosity for the Trp64Arg variant is unlikely to increase the risk of obesity, insulin resistance or type 2 diabetes. 16634992

2006

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE We studied possible relations between GDM and both insulin receptor substrate 1 (IRS-1) (Gly972Arg) and beta3-adrenergic receptor (ADRB3 Trp64Arg, beta3-AR) gene mutations, considered potential modifying factors in the etiology of type 2 diabetes mellitus. 17046546

2006

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). 17727676

2008

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Some studies indicate that the Trp64Arg polymorphism in the gene encoding the beta3-adrenergic receptor (ADRB3) is associated with obesity, insulin resistance and earlier onset of type 2 diabetes mellitus. 17852419

2007

dbSNP: rs4994
rs4994
0.100 GeneticVariation BEFREE Furthermore, the association of Trp64Arg with type 2 diabetes was examined in a meta-analysis. 18249022

2008